Chinh Pham-Trung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chinh Pham-Trung has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Diego Jiménez-Sánchez
Electrophysiology Unit (V.C.-U., M.S.-D., D.J.-S., C.A.-A., P.V.-M., A.L.-R., D.G.-R., D.S.-O., C.P.-T., E.G.-I., J.T.-R., I.F.-L.), Cardiology Service, Hospital Electrophysiology Unit Puerta de Hierro, Madrid, Spain
2 shared publications - Víctor Castro-Urda
Unidad de Arritmias, Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
2 shared publications Alvaro Lorente‐Ros
Electrophysiology Unit Cardiology Service. Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain
1 shared publicationBotti‐Sequera A
Electrophysiology Unit Cardiology Service, Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain
1 shared publication- Carlos Giuliani
Department of Cardiology, Hospital Universitario de La Princesa, IIS-IP, CIBER-CV, Madrid, Spain
1 shared publication Castro‐Urda V
Electrophysiology Unit Cardiology Service, Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain
1 shared publication
Latest Publications
- 20 February 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 49 (7) , 911-916
Left Bundle Branch Area Pacing as an Upgrade for Patients With Pacing‐Induced Ventricular Dysfunction
Background: Pacing‐induced cardiomyopathy (PIC) occurs in up to 30% of patients with conventional right ventricular (RV) pacing, often requiring upgrade to cardiac resynchronization therapy (CRT). Left bundle branch area pacing (LBBAP) offers a physiological alternative to biventricular pacing, but its role in PIC upgrades remains underexplored. Methods: We retrospectively analyzed 31 patients who underwent LBBAP upgrades for PIC between June 2020 and September 2024. Procedural success, electrical remodeling, echocardiographic changes, and clinical outcomes were assessed. Results: LBBAP was successful in 30 (97%) cases. Average procedure time was 80 (60–120) min. QRS duration significantly decreased (175 ± 17 ms to 130 ± 18 ms, p < 0.001). After a median 19 months of follow up, left ventricular ejection fraction (LVEF) improved from 33 ± 8% to 42 ± 8% ( p < 0.001). Three patients (9%) were hospitalized for heart failure, and five (16%) died during follow‐up. Conclusion: LBBAP is a safe and effective upgrade strategy for PIC, offering significant electrical and functional improvements. Further studies are needed to confirm its long‐term benefits compared to biventricular pacing.
- 20 February 2026
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 49 (7) , 911-916
Left Bundle Branch Area Pacing as an Upgrade for Patients With Pacing‐Induced Ventricular Dysfunction
Background: Pacing‐induced cardiomyopathy (PIC) occurs in up to 30% of patients with conventional right ventricular (RV) pacing, often requiring upgrade to cardiac resynchronization therapy (CRT). Left bundle branch area pacing (LBBAP) offers a physiological alternative to biventricular pacing, but its role in PIC upgrades remains underexplored. Methods: We retrospectively analyzed 31 patients who underwent LBBAP upgrades for PIC between June 2020 and September 2024. Procedural success, electrical remodeling, echocardiographic changes, and clinical outcomes were assessed. Results: LBBAP was successful in 30 (97%) cases. Average procedure time was 80 (60–120) min. QRS duration significantly decreased (175 ± 17 ms to 130 ± 18 ms, p < 0.001). After a median 19 months of follow up, left ventricular ejection fraction (LVEF) improved from 33 ± 8% to 42 ± 8% ( p < 0.001). Three patients (9%) were hospitalized for heart failure, and five (16%) died during follow‐up. Conclusion: LBBAP is a safe and effective upgrade strategy for PIC, offering significant electrical and functional improvements. Further studies are needed to confirm its long‐term benefits compared to biventricular pacing.
- 1 January 2025
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 18 (1) , e012917
Superior Vena Cava Isolation With Cryoballoon in AF Ablation: Randomized CAVAC AF Trial
BACKGROUND: Superior vena cava (SVC) has been considered a specific trigger in atrial fibrillation development. METHODS: We investigated the efficacy and safety of combining cryoballoon pulmonary vein isolation (PVI) with SVC ablation compared with PVI alone in 100 patients with paroxysmal or non–long-standing persistent atrial fibrillation. Patients were randomly assigned to either the PVI+SVC ablation group or the PVI-only group. Each patient was given a mobile device to record a daily ECG and detect atrial tachyarrhythmias. RESULTS: The primary end point, freedom from any atrial tachyarrhythmia recurrence between 91 and 365 days post-catheter ablation, did not significantly differ between the 2 groups (62.9% versus 72%; P =0.41). However, the PVI+SVC group exhibited higher rates of phrenic nerve paralysis (20.8% versus 6%; P =0.003) and transient sinus node injury (18.8% versus 0%; P =0.001) compared with the PVI-only group. The median burden of atrial tachyarrhythmia showed no significant difference ( P =0.91). CONCLUSIONS: The addition of SVC ablation to PVI did not enhance freedom from atrial tachyarrhythmia at 12 months, and it led to increased complications. These findings do not support the routine inclusion of SVC ablation in cryoballoon procedures for first-time catheter ablation in patients with paroxysmal or non–long-standing persistent atrial fibrillation.
- 1 January 2025
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 18 (1) , e012917
Superior Vena Cava Isolation With Cryoballoon in AF Ablation: Randomized CAVAC AF Trial
BACKGROUND: Superior vena cava (SVC) has been considered a specific trigger in atrial fibrillation development. METHODS: We investigated the efficacy and safety of combining cryoballoon pulmonary vein isolation (PVI) with SVC ablation compared with PVI alone in 100 patients with paroxysmal or non–long-standing persistent atrial fibrillation. Patients were randomly assigned to either the PVI+SVC ablation group or the PVI-only group. Each patient was given a mobile device to record a daily ECG and detect atrial tachyarrhythmias. RESULTS: The primary end point, freedom from any atrial tachyarrhythmia recurrence between 91 and 365 days post-catheter ablation, did not significantly differ between the 2 groups (62.9% versus 72%; P =0.41). However, the PVI+SVC group exhibited higher rates of phrenic nerve paralysis (20.8% versus 6%; P =0.003) and transient sinus node injury (18.8% versus 0%; P =0.001) compared with the PVI-only group. The median burden of atrial tachyarrhythmia showed no significant difference ( P =0.91). CONCLUSIONS: The addition of SVC ablation to PVI did not enhance freedom from atrial tachyarrhythmia at 12 months, and it led to increased complications. These findings do not support the routine inclusion of SVC ablation in cryoballoon procedures for first-time catheter ablation in patients with paroxysmal or non–long-standing persistent atrial fibrillation.
- 6 December 2023
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 47 (1) , 149-155
Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experience
BackgroundConventional right ventricle (RV) pacemaker stimulation has been associated with worse clinical outcomes in patients with cardiac amyloidosis (CA). Left bundle branch area pacing (LABPP) has been suggested as a promising alternative. We sought to assess the safety, feasibility, and outcomes of LABPP in patients with CA.MethodsWe retrospectively analyzed echocardiography and pacing parameters and clinical outcomes in 23 consecutive patients with CA and LBBAP implanted from June 2020 to October 2022.ResultsLBBAP was successfully performed in 22 over 23 patients (19 male, 78.6 +/- 11.7 years, 20 ATTR, mean LVEF 45.5 +/- 16.2%). After the procedure, 9 patients showed Qr pattern and 11 a qR pattern in V1 on ECG. Average procedure time was 67 +/- 28 min. After 7.7 +/- 5.2 months follow-up, no procedure-related complications had occurred. Although, a significant reduction in QRS width (p = .001) was achieved, we did not observe significant changes in LVEF and Nt ProBNP at 6 months of follow-up. Pacing parameters were stable during follow-up: LBB capture threshold and R wave amplitude were 1.0 +/- 0.5 V and 10.6 +/- 6.0 mV versus 0.8 +/- 0.1 V, p = .21 and 10.6 +/- 5.1 mV (p = .985) at follow up.ConclusionLBBAP is safe and feasible pacing technique for patients with CA. LBBAP is associated with significant narrowing of QRSd without worsening in LVEF and Nt-proBNP.
- 6 December 2023
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 47 (1) , 149-155
Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experience
BackgroundConventional right ventricle (RV) pacemaker stimulation has been associated with worse clinical outcomes in patients with cardiac amyloidosis (CA). Left bundle branch area pacing (LABPP) has been suggested as a promising alternative. We sought to assess the safety, feasibility, and outcomes of LABPP in patients with CA.MethodsWe retrospectively analyzed echocardiography and pacing parameters and clinical outcomes in 23 consecutive patients with CA and LBBAP implanted from June 2020 to October 2022.ResultsLBBAP was successfully performed in 22 over 23 patients (19 male, 78.6 +/- 11.7 years, 20 ATTR, mean LVEF 45.5 +/- 16.2%). After the procedure, 9 patients showed Qr pattern and 11 a qR pattern in V1 on ECG. Average procedure time was 67 +/- 28 min. After 7.7 +/- 5.2 months follow-up, no procedure-related complications had occurred. Although, a significant reduction in QRS width (p = .001) was achieved, we did not observe significant changes in LVEF and Nt ProBNP at 6 months of follow-up. Pacing parameters were stable during follow-up: LBB capture threshold and R wave amplitude were 1.0 +/- 0.5 V and 10.6 +/- 6.0 mV versus 0.8 +/- 0.1 V, p = .21 and 10.6 +/- 5.1 mV (p = .985) at follow up.ConclusionLBBAP is safe and feasible pacing technique for patients with CA. LBBAP is associated with significant narrowing of QRSd without worsening in LVEF and Nt-proBNP.